The present invention relates to compositions and methods for
destabilizing lysosomes to increase the degradation of oncogenic or
aberrant proteins for the prevention and treatment of disease. Methods
for identifying agents which destabilize lysosomes are also provided as
are agents identified in accordance with the screening method.